CAM
MGNX icon

ClariVest Asset Management’s MacroGenics MGNX Stock Holding History

ClariVest Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-117,919
Closed -$1.74M – 902
2024
Q1 		$1.74M Sell
117,919
-68,928
-37% -$1.04M 0.18% 168
2023
Q4 		$1.8M Buy
186,847
+89,247
+91% +$617K 0.1% 145
2023
Q3 		$455K Hold
97,600
– – 0.02% 353
2023
Q2 		$522K Buy
+97,600
New +$602K 0.03% 344
2020
Q2 		– Sell
-37,300
Closed -$217K – 815
2020
Q1 		$217K Sell
37,300
-2,400
-6% -$21.8K 0.01% 481
2019
Q4 		$432K Buy
39,700
+17,400
+78% +$172K 0.01% 441
2019
Q3 		$284K Sell
22,300
-300
-1% -$4.32K 0.01% 468
2019
Q2 		$384K Buy
22,600
+3,700
+20% +$63.6K 0.01% 385
2019
Q1 		$340K Buy
+18,900
New +$327K 0.01% 490
2017
Q1 		– Sell
-20,136
Closed -$411K – 725
2016
Q4 		$411K Sell
20,136
-19
-0.1% -$478 0.01% 419
2016
Q3 		$604K Sell
20,155
-40,141
-67% -$1.19M 0.02% 365
2016
Q2 		$1.63M Buy
60,296
+8,100
+16% +$183K 0.05% 245
2016
Q1 		$979K Buy
52,196
+2,049
+4% +$39K 0.03% 289
2015
Q4 		$1.55M Sell
50,147
-1,065
-2% -$32.4K 0.04% 223
2015
Q3 		$1.1M Sell
51,212
-23,568
-32% -$739K 0.03% 263
2015
Q2 		$2.84M Sell
74,780
-9,415
-11% -$309K 0.08% 161
2015
Q1 		$2.64M Sell
84,195
-836
-1% -$28.3K 0.08% 152
2014
Q4 		$2.98M Sell
85,031
-352
-0.4% -$8.78K 0.11% 108
2014
Q3 		$1.78M Buy
85,383
+8,932
+12% +$185K 0.07% 186
2014
Q2 		$1.66M Buy
+76,451
New +$1.61M 0.06% 193

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClariVest Asset Management's MGNX Position: Q2 2024 in Review

ClariVest Asset Management sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 117,919 shares — an estimated $1.74M sold.

ClariVest Asset Management first reported a position in MGNX in Q2 2014 and held it in 20 quarters. The position peaked at $2.98M in Q4 2014. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • ClariVest Asset Management reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • ClariVest Asset Management sold 117,919 MacroGenics shares in Q2 2024, an estimated $1.74M.
  • ClariVest Asset Management first reported a position in MacroGenics in Q2 2014 and held it in 20 quarters.
  • ClariVest Asset Management's MacroGenics position peaked at $2.98M in Q4 2014.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on ClariVest Asset Management's 13F filing for Q2 2024, filed 7 Aug 2024.